Skip to main content

Jeffrey S. Humphrey MD

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jeffrey S. Humphrey MD

Lantheus Holdings, Inc. reported in an 8-K filed May 15, 2024 that Jeffrey S. Humphrey MD was appointed Chief Medical Officer, effective May 28, 2024.

“Jeffrey S. Humphrey, MD has been appointed Chief Medical Officer (CMO) and Jean-Claude Provost, MD has been named Chief Science Officer (CSO), effective May 28, 2024.”
Lantheus Holdings, Inc. Form 8-K, filed May 15, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Lantheus Holdings, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.